{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:06Z","timestamp":1789726266297,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Severe hypofibrinogenemia after intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is rare and easily overlooked, but hypofibrinogenemia increases the risk of major bleeding. However, it is unclear when hypofibrinogenemia reaches the peak and when hypofibrinogenemia is resolved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>Case 1 was of a 66-year-old man who was hospitalized due to sudden onset of vague speech and right hemiplegia for 4\u200ahours. Case 2 was of an 84-year-old woman who was hospitalized for sudden onset of left hemiplegia and vague speech for 4\u200ahours. In case 1, fibrinogen levels decreased from normal values to &lt;0.25\u200ag\/L within 4.5\u200ahours after commencing IVT and returned to normal at 35\u200ahours later. In case 2, fibrinogen levels decreased from 1.1 to &lt;0.25\u200ag\/L within 2\u200ahours after commencing IVT and normalized 36.5\u200ahours later.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Both patients were diagnosed with rt-PA-related hypofibrinogenemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>No antiplatelet or symptomatic treatment was administered during the period of hypofibrinogenemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Fibrinogen levels gradually recovered. In case 1, the patient did not experience cerebral hemorrhage during hypofibrinogenemia. His symptoms improved significantly within 1\u200aweek. In case 2, repeat computed tomography revealed minor cerebral hemorrhage, but no deterioration in her condition was noted until she was discharged.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Rapid, severe, and prolonged hypofibrinogenemia may occur after IVT with rt-PA, which may increase the risk of massive hemorrhage and affect the related therapy. Prompt diagnosis of hypofibrinogenemia is important for preventing complications. We recommend checking the fibrinogen levels routinely after IVT. Fibrinogen replacement therapy and platelet transfusion are the main management routes for rt-PA-related symptomatic intracranial hemorrhage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024978","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T12:38:36Z","timestamp":1614775116000},"page":"e24978","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Rare severe hypofibrinogenemia induced by tissue plasminogen activator in stroke patients"],"prefix":"10.1097","volume":"100","author":[{"given":"Xuming","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Shenzhen Baoan Shiyan People's Hospital"},{"name":"Shenzhen Baoan People's Hospital (group) The Second People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-9347","authenticated-orcid":false,"given":"Liming","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen University First Affiliated Hospital"},{"name":"Department of Neurology, The 3rd Affiliated Hospital of Shenzhen University, Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1538574413497107","article-title":"Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis","volume":"47","author":"Skeik","year":"2013","journal-title":"Vasc Endovascular Surg"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000339675","article-title":"Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions","volume":"34","author":"Seet","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"R3-20250612","first-page":"1","article-title":"Hypofibrinogenemia and abnormal INR after treatment with systemic recombinant tissue plasminogen activator for acute ischemic stroke","volume":"40","author":"Smith","year":"2012","journal-title":"Crit Care Med"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.thromres.2012.11.009","article-title":"Characterization of severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke","volume":"131","author":"Matrat","year":"2013","journal-title":"Thromb Res"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.005","article-title":"Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage","volume":"24","author":"Vandelli","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1258\/0004563042466884","article-title":"Plasma fibrinogen","volume":"41","author":"Lowe","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.wneu.2017.01.091","article-title":"Risk factors for hemorrhagic transformation following intravenous thrombolysis in acute cerebral infarction: a retrospective single center study","volume":"101","author":"Xu","year":"2017","journal-title":"World Neurosurg"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1212\/WNL.0b013e3182897015","article-title":"Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis","volume":"80","author":"Matosevic","year":"2013","journal-title":"Neurology"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2015.02.048","article-title":"Early fibrinogen degradation coagulopathy: a predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis","volume":"351","author":"Sun","year":"2015","journal-title":"J Neurol Sci"},{"key":"R10-20250612","first-page":"3","article-title":"Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis","volume":"97","author":"Lu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in myocardial infarction (TIMI) trial\u2014Phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0016-5085(64)80031-7","article-title":"Hypofibrinogenemia without fibrinolysis due to cirrhosis: report of a rare occurrence","volume":"46","author":"Parker","year":"1964","journal-title":"Gastroenterology"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2147\/DDDT.S66868","article-title":"Transient hypofibrinogenemia due to allopurinol","volume":"8","author":"Yin","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.braindev.2014.03.004","article-title":"Hypofibrinogenemia caused by adrenocorticotropic hormone for infantile spasms: a case report","volume":"37","author":"Kamei","year":"2015","journal-title":"Brain Dev"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/STROKEAHA.119.025711","article-title":"Early fibrinogen depletion and symptomatic intracranial hemorrhage after reperfusion therapy","volume":"50","author":"Yan","year":"2019","journal-title":"Stroke"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.STR.0000226897.43749.27","article-title":"Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9149(98)00018-6","article-title":"Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction","volume":"81","author":"Stangl","year":"1998","journal-title":"Am J Cardiol"},{"key":"R18-20250612","first-page":"666","article-title":"Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2018","volume":"51","year":"2018","journal-title":"Chin J Neurol"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JBM.S90693","article-title":"Acquired hypofibrinogenemia: current perspectives","volume":"7","author":"Besser","year":"2016","journal-title":"J Blood Med"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.12107","article-title":"Guideline on the management of bleeding in patients on antithrombotic agents","volume":"160","author":"Makris","year":"2013","journal-title":"Br J Haematol"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acuteischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke"},{"key":"R22-20250612","first-page":"1711","article-title":"Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association","volume":"27","author":"Adams","year":"1996","journal-title":"Stroke"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:01:14Z","timestamp":1749754874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024978"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024978","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"2020-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}